Moody s est en passe d acquérir Cortera, un leader des données et des informations de crédit silicon.fr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from silicon.fr Daily Mail and Mail on Sunday newspapers.
Operator
Good morning, ladies and gentlemen, and welcome to Haynes International Inc. First Quarter Fiscal 2021 Financial Results Conference Call. [Operator Instructions]
It is now my pleasure to turn the floor over to your host, David Van Bibber. Sir, the floor is yours.
David Van Bibber
Controller and Chief Accounting Officer
Thank you very much for joining us today. With me today are Mike Shor, President and CEO of Haynes International; and Dan Maudlin, Vice President and Chief Financial Officer. Before we get started, I would like to read a brief cautionary note regarding forward-looking statements. This conference call contains statements that are forward-looking within the meaning of the Private Securities Litigation and Reform Act of 1995 and Section 21E of the Securities and Exchange Act of 1934. The words believe, anticipate, plan and similar expressions are intended to identify forward-looking statements. Although we believe our plans, intentions and expectations re
Merus N V annonce le projet d appel public à l épargne par émission d actions ordinaires globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference
Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference
CHARLOTTESVILLE, Va., Jan. 11, 2021 Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) (“Diffusion” or “the Company”), today announced that the Company is participating in the H.C. Wainwright BioConnect 2021 Conference being held virtually January 11-14, 2021. Conference specifics are as follows:
Event:
Date:
The recorded presentation can be accessed by conference participants and the presentation deck can be accessed on the investor relations section of the Diffusion Pharmaceuticals’ website.
About Diffusion Pharmaceuticals Inc. Diffusion Pharmaceuticals Inc. is an innovative biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to the areas where it is needed most. Diffusion’s lead product candidate, trans sodium crocetinate, is being develo
Cintas Corporation : annonce ses résultats pour le second trimestre de son exercice 2021 zonebourse.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from zonebourse.com Daily Mail and Mail on Sunday newspapers.